Na Luo - Search Results

Year	Number of Results
2003	1
2005	1
2006	6
2007	4
2008	3
2009	1
2010	14
2011	8
2012	15
2013	10
2014	18
2015	14
2016	11
2017	18
2018	22
2019	21
2020	30
2021	38
2022	61
2023	53
2024	16

1

PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review.

Song J, Lan J, Tang J, Luo N. Song J, et al. Among authors: luo n. Int J Mol Sci. 2022 Sep 2;23(17):10025. doi: 10.3390/ijms231710025. Int J Mol Sci. 2022. PMID: 36077422 Free PMC article. Review.

2

A literature review of the promising future of TROP2: a potential drug therapy target.

Wen Y, Ouyang D, Zou Q, Chen Q, Luo N, He H, Anwar M, Yi W. Wen Y, et al. Among authors: luo n. Ann Transl Med. 2022 Dec;10(24):1403. doi: 10.21037/atm-22-5976. Ann Transl Med. 2022. PMID: 36660684 Free PMC article. Review.

3

MC4R-dependent suppression of appetite by bone-derived lipocalin 2.

Mosialou I, Shikhel S, Liu JM, Maurizi A, Luo N, He Z, Huang Y, Zong H, Friedman RA, Barasch J, Lanzano P, Deng L, Leibel RL, Rubin M, Nickolas T, Chung W, Zeltser LM, Williams KW, Pessin JE, Kousteni S. Mosialou I, et al. Among authors: luo n. Nature. 2017 Mar 16;543(7645):385-390. doi: 10.1038/nature21697. Epub 2017 Mar 8. Nature. 2017. PMID: 28273060 Free PMC article.

4

A systematic review and meta-analysis of the effectiveness and safety of COVID-19 vaccination in older adults.

Xu K, Wang Z, Qin M, Gao Y, Luo N, Xie W, Zou Y, Wang J, Ma X. Xu K, et al. Among authors: luo n. Front Immunol. 2023 Mar 3;14:1113156. doi: 10.3389/fimmu.2023.1113156. eCollection 2023. Front Immunol. 2023. PMID: 36936964 Free PMC article.

5

Advances in Targeted Immunotherapy in Cancers.

Luo N. Luo N. Int J Mol Sci. 2023 Dec 14;24(24):17475. doi: 10.3390/ijms242417475. Int J Mol Sci. 2023. PMID: 38139301 Free PMC article.

6

Pharmacological inhibition of protein S-palmitoylation suppresses osteoclastogenesis and ameliorates ovariectomy-induced bone loss.

Ma L, Zhang L, Liao Z, Xiu C, Luo X, Luo N, Zhang L, He G, Chen J. Ma L, et al. Among authors: luo n. J Orthop Translat. 2023 Jul 17;42:1-14. doi: 10.1016/j.jot.2023.06.002. eCollection 2023 Sep. J Orthop Translat. 2023. PMID: 37521493 Free PMC article.

7

[Cholesterol Metabolism and Tumor Immunity].

Luo N, Shi RC, Dai RY, Miao HM. Luo N, et al. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 Mar;53(2):335-341. doi: 10.12182/20220360202. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35332739 Free PMC article. Review. Chinese.

8

A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis.

Hu Y, He Y, Luo N, Li X, Guo L, Zhang K. Hu Y, et al. Among authors: luo n. Cancer Biol Ther. 2023 Dec 31;24(1):2235768. doi: 10.1080/15384047.2023.2235768. Cancer Biol Ther. 2023. PMID: 37548553 Free PMC article.

9

Cuprotosis clusters predict prognosis and immunotherapy response in low-grade glioma.

Zhu W, Chen Z, Fu M, Li Q, Chen X, Li X, Luo N, Tang W, Yang F, Zhang Y, Zhang Y, Peng X, Hu G. Zhu W, et al. Among authors: luo n. Apoptosis. 2024 Feb;29(1-2):169-190. doi: 10.1007/s10495-023-01880-y. Epub 2023 Sep 15. Apoptosis. 2024. PMID: 37713112 Free PMC article.

10

Protective role of the novel cytokine Metrnl/ interleukin-41 in host immunity defense during sepsis by promoting macrophage recruitment and modulating Treg/Th17 immune cell balance.

Chen X, Chen X, Yang Y, Luo N, Yang J, Zhong L, Guo T, Yuan Z, Wei Q, Wang C. Chen X, et al. Among authors: luo n. Clin Immunol. 2023 Sep;254:109690. doi: 10.1016/j.clim.2023.109690. Epub 2023 Jul 7. Clin Immunol. 2023. PMID: 37423488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

332 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

332 results

Results by year